Table 3.
AAIR of HCC in India (IARC–WHO).5
| Male |
Female |
|||||
|---|---|---|---|---|---|---|
| Cases | ASR | Cum | Cases | ASR | Cum | |
| Chennai | 269 | 3.0 | 0.37 | 83 | 0.9 | 0.10 |
| New Delhi | 491 | 2.4 | 0.28 | 232 | 1.3 | 0.16 |
| Karunagappally | 34 | 3.9 | 0.43 | 8 | 0.8 | 0.10 |
| Mumbai | 895 | 4.5 | 0.56 | 433 | 2.2 | 0.25 |
| Nagpur | 65 | 1.6 | 0.19 | 35 | 0.9 | 0.10 |
| Poona | 209 | 3.4 | 0.41 | 88 | 1.4 | 0.15 |
| Trivandrum | 78 | 2.8 | 0.32 | 30 | 1.0 | 0.12 |
International Agency for Research on Cancer (IARC–WHO).
Age–standardized (per 100,000) and cumulative 0–74 incidence (%) rates http://Ci5.iarc.fr.